Hangcheng Zhou

915 total citations
37 papers, 740 citations indexed

About

Hangcheng Zhou is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Hangcheng Zhou has authored 37 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Molecular Biology and 11 papers in Surgery. Recurrent topics in Hangcheng Zhou's work include Pancreatic and Hepatic Oncology Research (7 papers), Gastric Cancer Management and Outcomes (6 papers) and Pancreatitis Pathology and Treatment (4 papers). Hangcheng Zhou is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Gastric Cancer Management and Outcomes (6 papers) and Pancreatitis Pathology and Treatment (4 papers). Hangcheng Zhou collaborates with scholars based in China and Japan. Hangcheng Zhou's co-authors include Ren-bao Yang, Yun-lian Xia, Lu Yin, Liwei Hu, Jiong Chen, Jiong Chen, Longjiang Chen, Wen Wu, Jinliang Ma and Ge‐Liang Xu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Optics Letters and European Journal of Cancer.

In The Last Decade

Hangcheng Zhou

31 papers receiving 737 citations

Peers

Hangcheng Zhou
Hangcheng Zhou
Citations per year, relative to Hangcheng Zhou Hangcheng Zhou (= 1×) peers Hongyu Zhang

Countries citing papers authored by Hangcheng Zhou

Since Specialization
Citations

This map shows the geographic impact of Hangcheng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hangcheng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hangcheng Zhou more than expected).

Fields of papers citing papers by Hangcheng Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hangcheng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hangcheng Zhou. The network helps show where Hangcheng Zhou may publish in the future.

Co-authorship network of co-authors of Hangcheng Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Hangcheng Zhou. A scholar is included among the top collaborators of Hangcheng Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hangcheng Zhou. Hangcheng Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Yuan, Huiquan Liu, Xiaoyang Li, et al.. (2025). Neoadjuvant chemoradiation with camrelizumab and nimotuzumab for initially inoperable esophageal squamous cell carcinoma: A single-arm phase 2 trial. European Journal of Cancer. 228. 115717–115717.
2.
3.
Zhou, Hangcheng, Ping Gu, Wei Cui, et al.. (2024). Tumour response following preoperative chemotherapy is affected by body mass index in patients with colorectal liver metastases. World Journal of Gastrointestinal Oncology. 16(2). 331–342. 2 indexed citations
4.
Chen, Xiaohong, Hangcheng Zhou, Li Tian, et al.. (2024). Prognostic impact of spread through air spaces in patients with ≤2 cm stage IA lung adenocarcinoma. Journal of Thoracic Disease. 16(4). 2432–2442. 7 indexed citations
5.
Zhou, Hangcheng, et al.. (2022). The prognostic influence of histological subtypes of micropapillary tumors on patients with lung adenocarcinoma ≤ 2 cm. Frontiers in Oncology. 12. 954317–954317. 7 indexed citations
6.
Liu, Dehua, Si Chen, Yawen Gou, et al.. (2021). Gastrointestinal Microbiota Changes in Patients With Gastric Precancerous Lesions. Frontiers in Cellular and Infection Microbiology. 11. 749207–749207. 37 indexed citations
7.
Wang, Jing, Pengfei Kong, Haiyun Wang, et al.. (2020). Identification of a Gene-Related Risk Signature in Melanoma Patients Using Bioinformatic Profiling. Journal of Oncology. 2020. 1–13. 13 indexed citations
8.
Liu, Dehua, Yawen Gou, Hangcheng Zhou, et al.. (2020). Gastrointestinal Microbiota Changes in Patients With Gastric Precancerous Lesions. SSRN Electronic Journal. 3 indexed citations
9.
Ni, Ming, Qiang Xie, & Hangcheng Zhou. (2019). 18F-FDG PET/CT imaging in tracheal Rosai-Dorfman disease: a case report. 39(9). 546–547. 1 indexed citations
10.
Luo, Peng, Yuanyuan Ye, Ju Zhang, et al.. (2019). MiR-223-3p functions as a tumor suppressor in lung squamous cell carcinoma by miR-223-3p-mutant p53 regulatory feedback loop. Journal of Experimental & Clinical Cancer Research. 38(1). 74–74. 38 indexed citations
11.
Hu, Lei, Nianan He, Lei Ye, et al.. (2018). Evaluation of the Stiffness of Tissues Surrounding Thyroid Nodules with Shear Wave Elastography. Journal of Ultrasound in Medicine. 37(9). 2251–2261. 8 indexed citations
12.
Xu, Yan, et al.. (2018). Effects of metformin on prostatic tissue of rats with metabolic syndrome and benign prostatic hyperplasia. International Urology and Nephrology. 50(4). 611–617. 11 indexed citations
13.
Jia, Wei, et al.. (2016). Co-expression of periostin and EGFR in patients with esophageal squamous cell carcinoma and their prognostic significance. OncoTargets and Therapy. Volume 9. 5133–5142. 16 indexed citations
14.
Wang, Wei, Guangyao Li, Jianyu Zhu, et al.. (2015). Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma. Medical Oncology. 32(4). 131–131. 26 indexed citations
15.
Wang, Wei, et al.. (2014). High expression of periostin is dramatically associated with metastatic potential and poor prognosis of patients with osteosarcoma. World Journal of Surgical Oncology. 12(1). 287–287. 24 indexed citations
16.
17.
Chen, Jiong, Longjiang Chen, Yun-lian Xia, et al.. (2013). Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 139(7). 1117–1127. 31 indexed citations
18.
Sun, Qikai, Jianyu Zhu, Wei Wang, et al.. (2013). Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma. Medical Oncology. 31(1). 786–786. 53 indexed citations
19.
Lv, Yang, Weidong Jia, Qikai Sun, et al.. (2012). High-level expression of periostin is closely related to metastatic potential and poor prognosis of hepatocellular carcinoma. Medical Oncology. 30(1). 385–385. 42 indexed citations
20.
Chen, Jiong, Ren-bao Yang, Lu Yin, Yun-lian Xia, & Hangcheng Zhou. (2012). Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for solid pancreatic lesion: a systematic review. Journal of Cancer Research and Clinical Oncology. 138(9). 1433–1441. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026